Phase 2 Study of Novel Vaccine Underway in Newly Diagnosed Glioblastoma
Patients with newly diagnosed glioblastoma are now being accepted at two institutions to enter a phase 2 study to assess the efficacy of the SurVaxM vaccine in combination with standard chemotherapy.
Read More